소아 복막투석환자에서 혈관내피성장인자 유전자 다형성이 복막의 용질이동성에 미치는 영향 = Influence of VEGF Genetic Polymorphism on Peritoneal Solute Transport in Pediatric Dialysis Patients

국문 초록 (Abstract)

목 적 : 복막투석환자에서 복막의 용질이동성에 영향을 미치는 요인으로 유전적 요인과 임상적 요인이 있다. 복막평형검사는 복막투석환자의 복막 용질이동속도를 평가하는 데에 유용한 검사로, 본 연구에서는 소아 복막투석 환자에서 복막평형검사 결과를 이용하여 혈관내피성장인자(VEGF)의 유전자 다형성과 복막 용질이동성의 상관관계를 연구하였다. 방 법 : 서울대학교 어린이병원과 삼성서울병원의 소아 복막투석환자 중에서 복막염의 병력이 없고 복막투석 시작한 지 1년 이내에 복막평형검사가 시행된 환자를 대상으로 하였다. VEGF 유전자 -2578 C/A, -14978T/C, -1154G/A, -634G/C, +936 C/T의 단일 유전자다형성분석을 시행하였고 VEGF 유전자 다형성의 분포와 복막평형검사 결과간의 상관관계를 분석하였다. 결 과 : 복막평형검사를 분석한 결과, 4시간 크레아티닌의 투석액/혈장비(D/P creatinine)는 $0.56{\pm}0.13$였고 4시간 투석액/0시간투석액포도당비(D/$D_0$ glucose)는 $0.43{\pm}0.11$였다. 배수체 CTGGC의 이형접합체 또는 동형접합체인 경우가 배수체 CTGGC를 가지지 않은 경우에 비해 높은 4시간 D/P creatinine ($0.67{\pm}0.12$ vs $0.50{\pm}0.09$, P=0.007)과 은 4시간 D/$D_0$ glucose ($0.35{\pm}0.12$ vs $0.47{\pm}0.08$, P=0.037)를 보였다. 결 론 : VEGF 유전자 다형성은 복막 용질이동성에 영향을 미칠 수 있다.

다국어 초록 (Multilingual Abstract)

Purpose : Genetic and clinical factors can influence the permeability of the peritoneal membrane. The peritoneal equilibration test (PET) is helpful in measuring peritoneal permeability in peritoneal dialysis (PD). We investigated the influence of genetic polymorphism of vascular endothelial growth factor (VEGF) on the PET parameters. Methods : Pediatric patients who underwent PET within 12 months of initiating PD at Seoul National University Children's Hospital and Samsung Medical Center were selected. The patients with positive history of peritonitis before PET were excluded. The VEGF -2578C/A, -14978T/C, -1154G/A, -634G/C, and +936C/T single-nucleotide polymorphisms were genotyped. Results : The mean 4-hour dialysate-to-plasma ratio for creatinine (D/P creatinine) and the mean 4-hour dialysate glucose to baseline dialysate glucose ratio (D/$D_0$ glucose) were $0.56{\pm}0.13$ and $0.43{\pm}0.11$, respectively. The patients with haplotype CTGGC showed higher 4-hour D/P creatinine ($0.67{\pm}0.12$ vs $0.50{\pm}0.09$, P=0.007) and lower 4-hour D/$D_0$ glucose ($0.35{\pm}0.12$ vs $0.47{\pm}0.08$, P=0.037) than those without haplotype CTGGC. Conclusion : The VEGF genetic polymorphism may influence the peritoneal solute transport.

참고문헌 (Reference)

1 Combet S, "Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis" 11 : 717-728, 2000

2 Shahbazi M, "Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection" 13 : 260-264, 2002

3 Miyata T, "Toward better dialysis compatibility: Advances in the biochemistry and pathophysiology of the peritoneal membranes" 61 : 375-386, 2002

4 Rumpsfeld M, "Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients" 43 : 492-501, 2004

5 Pecoits-Filho R, "Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate" 17 : 1480-1486, 2002

6 Davies SJ, "Peritoneal solute transport--we know it is important, but what is it?" 15 : 1120-1123, 2000

7 Warady BA, "Peritoneal membrane transport function in children receiving long-term dialysis" 7 : 2385-2391, 1996

8 Twardowski ZJ, "Peritoneal equilibration test" 7 : 138-148, 1987

9 Gillerot G, "Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis" 60 : 1-6, 2003

10 Davies SJ, "Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients" 66 : 2437-2445, 2004

11 Watson CJ, "Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production" 12 : 1232-1235, 2000

12 Szeto C-C, "Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients" 65 : 1947-1955, 2004

13 Gillerot G, "Genetic and clinical factors influence the baseline permeability of the peritoneal membrane" 67 : 2477-2487, 2005

14 Passlick-Deetjen J, "Changes of peritoneal membrane function during long-term CAPD" 6 : 35-43, 1990

15 Yoshino A, "Changes in peritoneal equilibration test values during long-term peritoneal dialysis in peritonitis- free children" 21 : 180-185, 2001

16 Schneider BP, "Association of polymorphisms of angiogenesis genes with breast cancer" 111 : 157-163, 2008

17 Wong T, "Association of ENOS polymorphism with basal peritoneal membrane function in uremic patients" 42 : 781-786, 2003

18 Margetts PJ, "Acquired ultrafiltration dysfunction in peritoneal dialysis patients" 13 : 2787-2794, 2002

19 Renner W, "A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels" 37 : 443-448, 2000